Status:

COMPLETED

64Cu-DOTATATE PET-CT-skanning and Infective Endocarditis.

Lead Sponsor:

Emil Loldrup Fosbol

Conditions:

Endocarditis

Endocarditis;Chronic

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The investigators hypothesize that the 64Cu-DOTATATE will show uptake in the infected vegetations on the prosthetic heart valves and increase the accuracy of the right diagnosis - thus increasing the ...

Detailed Description

Infective endocarditis (IE) is an infection of the heart lining, primarily mediated by an endothelial injury causing activation of inflammatory cytokines and cells thus forming a thrombus creating a b...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years old
  • Be able to understand given information and sign informered consent
  • Group A: native heart valves without clinical or paraclinical sign of infection
  • Group B: native heart valves with verified endocarditis (according to modified Duke-criteria)
  • Group C: prothethic heart valves(mechanical or biological) without clinical or paraclinical sign of infection and more \>1 year sind the heart operation
  • Group D: infected prothethic heart valves, in addition clinical and paraclinical signs of infection (blood cultures and samples) and echocardiography
  • Group E: newly operated in the heart valves without infection (6 months since operation)
  • Group F: newly heart valve operation due to endocarditis (6 monts since operation)
  • Group G: chronical infection in the aortic valce - lifelong antibiotics.

Exclusion

  • allergi for 64Cu-DOTATATE or 18-FDG
  • obesity(weight over 140 kg)
  • critically ill, and PET scan not possible
  • Pregnancy or suspected pregnancy - negativ hCG will be required for fertile women
  • severe claustrophobia
  • diabetes - defined by farmacological treatment
  • recent heart operation(\<4 weeks)

Key Trial Info

Start Date :

April 28 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 29 2023

Estimated Enrollment :

69 Patients enrolled

Trial Details

Trial ID

NCT05432427

Start Date

April 28 2022

End Date

September 29 2023

Last Update

December 27 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rigshospitalet

Copenhagen, Capital Region, Denmark, 2100